Figure 5.

The correlation analysis between MDSCs levels and IPI scoring system in different status of B‐NHL patients. (A, B) No significant difference was detected between levels of M‐MDSC% or G‐MDSC% and IPI scoring system in ND patients. (C, D) No significant difference was detected between levels of M‐MDSC% or G‐MDSC% and IPI scoring system in remission patients. (E, F) No significant difference was detected between levels of M‐MDSC% or G‐MDSC% and IPI scoring system in relapsed patients. B‐NHL, B‐cell non‐Hodgkin lymphoma; G‐MDSCs, granulocytic‐myeloid‐derived suppressor cells; IPI, International Prognostic Index; M‐MDSCs, monocytic‐MDSC; ND, newly diagnosed